3-Aryl-1,2-diacetamidopropane Derivatives as Novel and Potent NK-1 Receptor Antagonists
Year: 1996
Type: article
Source: Journal of Medicinal Chemistry
DOI: 10.1021/jm950616c
Authors: Philip A. Hipskind, J. Jeffry Howbert, Robert F. Bruns, Steven S. Y. Cho, Thomas A. Crowell, Mark M. Foreman, Donald R. Gehlert, Smriti Iyengar, Kirk W. Johnson, Joseph H. Krushinski, Dominic L. Li, Karen L. Lobb, Norman R. Mason, Brian S. Muehl, James A. Nixon, Lee A. Phebus, Domenico Regoli, Rosa M. Simmons, Penny G. Threlkeld, Diane C. Waters, Bruce D. Gitter
Institutions: Université de Sherbrooke, Eli Lilly (United States)
Language: English
Subfield: Cellular and Molecular Neuroscience
Field: Neuroscience
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2054549257